Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2002-2-6
pubmed:abstractText
In a pilot study, the anti-tumour necrosis factor alpha monoclonal antibody, infliximab, induced a rapid and significant improvement in global, peripheral, and axial disease manifestations of patients with active spondyloarthropathy.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/11830424-10228190, http://linkedlifedata.com/resource/pubmed/commentcorrection/11830424-10229436, http://linkedlifedata.com/resource/pubmed/commentcorrection/11830424-10325662, http://linkedlifedata.com/resource/pubmed/commentcorrection/11830424-10555027, http://linkedlifedata.com/resource/pubmed/commentcorrection/11830424-10834859, http://linkedlifedata.com/resource/pubmed/commentcorrection/11830424-10857793, http://linkedlifedata.com/resource/pubmed/commentcorrection/11830424-10972371, http://linkedlifedata.com/resource/pubmed/commentcorrection/11830424-11083258, http://linkedlifedata.com/resource/pubmed/commentcorrection/11830424-11117919, http://linkedlifedata.com/resource/pubmed/commentcorrection/11830424-1561402, http://linkedlifedata.com/resource/pubmed/commentcorrection/11830424-1930310, http://linkedlifedata.com/resource/pubmed/commentcorrection/11830424-2181127, http://linkedlifedata.com/resource/pubmed/commentcorrection/11830424-3283358, http://linkedlifedata.com/resource/pubmed/commentcorrection/11830424-357213, http://linkedlifedata.com/resource/pubmed/commentcorrection/11830424-6231933, http://linkedlifedata.com/resource/pubmed/commentcorrection/11830424-6712754, http://linkedlifedata.com/resource/pubmed/commentcorrection/11830424-6971529, http://linkedlifedata.com/resource/pubmed/commentcorrection/11830424-7699629, http://linkedlifedata.com/resource/pubmed/commentcorrection/11830424-7699630, http://linkedlifedata.com/resource/pubmed/commentcorrection/11830424-7748217, http://linkedlifedata.com/resource/pubmed/commentcorrection/11830424-7799351, http://linkedlifedata.com/resource/pubmed/commentcorrection/11830424-7934491, http://linkedlifedata.com/resource/pubmed/commentcorrection/11830424-8099520, http://linkedlifedata.com/resource/pubmed/commentcorrection/11830424-8232330, http://linkedlifedata.com/resource/pubmed/commentcorrection/11830424-8575136, http://linkedlifedata.com/resource/pubmed/commentcorrection/11830424-8961905, http://linkedlifedata.com/resource/pubmed/commentcorrection/11830424-8961906, http://linkedlifedata.com/resource/pubmed/commentcorrection/11830424-9321530, http://linkedlifedata.com/resource/pubmed/commentcorrection/11830424-9361156, http://linkedlifedata.com/resource/pubmed/commentcorrection/11830424-9376990, http://linkedlifedata.com/resource/pubmed/commentcorrection/11830424-9558175, http://linkedlifedata.com/resource/pubmed/commentcorrection/11830424-9710889, http://linkedlifedata.com/resource/pubmed/commentcorrection/11830424-9751087
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0003-4967
pubmed:author
pubmed:issnType
Print
pubmed:volume
61
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
207-12
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2002
pubmed:articleTitle
Repeated infusions of infliximab, a chimeric anti-TNFalpha monoclonal antibody, in patients with active spondyloarthropathy: one year follow up.
pubmed:affiliation
Department of Rheumatology, Ghent University Hospital, Belgium. elli.kruithof@rug.ac.be
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't